Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Phenotype Transition in Pemphigus May Suggest Undertreatment with Rituximab: Findings from a Retrospective Single-Centre Analysis of Relapsed Patients.

Dermatology (Basel, Switzerland) - 1 Jan 2026

Strandmoe Anne-Lise, Hiel Marjolein A J, Meijer Joost M, van Nijen-Vos Laura L, Nijenhuis A Miranda, van Pelt L Joost, Meijer Gonnie H J, Heeringa Peter, Diercks Gilles F H, Bremer Jeroen, Horváth Barbara

Abstract excerpt

<p>Introduction: Pemphigus is an autoimmune bullous disease caused by autoantibodies against desmoglein (DSG) 1 and/or 3 and comprises two main subtypes: pemphigus vulgaris (PV) and pemphigus foliaceus (PF). PV affects the skin and/or mucosa and includes two forms: mucocutaneous PV (mcPV; anti-DSG1 and anti-DSG3) and mucosal PV (mPV; anti-DSG3). PF, characterized by anti-DSG1 autoantibodies, is limited to the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Autoantibodies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Desmoglein 1

Share to Immunologic Factors

Share to Pemphigus

Share to Phenotype

Share to Recurrence

Share to Rituximab

Source

Open in PubMed Open full text

Identifiers

PMID: 41553945
DOI: 10.1159/000550300
PMCID: PMC12991809

Genes

DSG3
DSG1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Phenotype Transition in Pemphigus May Suggest Undertreatment with Rituximab: Findings from a Retrospective Single-Centre Analysis of Relapsed Patients.PMID 41553945Read ↗

Beyond the skin: B cells in pemphigus vulgaris, tolerance and treatmentSemantic proximity Read ↗

Clinical manifestation variability of bullous pemphigoid.Semantic proximity Read ↗

A clinically actionable stratification of bullous pemphigoid using a disease activity score reveals a targetable inflammatory endotype.Semantic proximity Read ↗

Efficacy and safety of tofacitinib in treatment of pemphigus: a single-center cohort studySemantic proximity Read ↗

Rituximab tunes desmoglein-3-specific follicular T cells in patients with pemphigus vulgarisSemantic proximity Read ↗

Distinct Clinical Phenotypes and Treatment Responses in IgG4-Related Disease: Insights From a Tertiary Care Centre in Western India.Semantic proximity Read ↗

Pemphigus vulgaris: a clinical study of 44 cases over a 20-year period.Semantic proximity Read ↗

Pemphigus herpetiformis: analysis of the autoantibody profile during the disease course with changes in the clinical phenotype.Semantic proximity Read ↗

Specific immunoglobulin isotypes correlate with disease activity, morphology, duration and HLA association in Pemphigus vulgaris.Semantic proximity Read ↗

Evaluation of Papanicolaou smears in pemphigus vulgaris patients before and after rituximabSemantic proximity Read ↗

B-cell depletion immunotherapy in pemphigus: effects on cellular and humoral immune responses.Semantic proximity Read ↗

Are clinical phenotype and autoantibody profile always concordant in pemphigus? A study in a cohort of pemphigus patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.